Center for Patient Safety at the End of Life
临终患者安全中心
基本信息
- 批准号:6528293
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-30 至 2004-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The RAND Center to Improve Care of the Dying will generate a new Developmental Center for Evaluation and Research in Patient Safety: the Center for Patient Safety at the End of Life. The Center will be led by Dr. Joanne Lynn and will build on experts from RAND Health, the Institute for Healthcare Improvement, The Veterans Health Administration, Kaiser Permanente, and other organizations. These leaders in health services research and quality improvement are committed to making care safe and reliable for persons with serious eventually fatal chronic illness, staring with those with advanced chronic heart or lung failure. Although they have the potential to affect the health care provided to all Americans, medical errors and other lapses in patient safety disproportionately affect the oldest and sickest of patients, both in their incidence and in the severity of the consequences. Serious, long-term illness occurs mostly at the end of life-leading to more errors, adverse effects, and erratic and unsafe treatment patients in a population that is most in need of safe, reliable, coordinated care. Seriously ill patients are often subjected to a repeated series of mistakes, including: non-treatment of pain, delirium, and other symptoms; routine discontinuity within and among provider programs; location of care for provider convenience, rather than efficiency or family support; and a lack of focus on advance care planning. The Center aims to help improve the reliability of health care dramatically, by building capacity for improvement through effective change methods and knowledge about safe and correct care of individuals with chronic heart failure of chronic obstructive pulmonary disease. During Phase I, the Center will build a strong team, develop ties to health delivery systems, produce educational materials, and develop a proposal for at least one pilot study that it will carry out during Years 2 and 3. In Phase II, the Center will implement the pilot study(ies), present educational materials, and develop a dissemination for pilot study findings.
兰德改善临终关怀中心将成立一个新的患者安全评估和研究发展中心:生命末期患者安全中心。该中心将由乔安妮林恩博士领导,并将建立在来自兰德健康,医疗保健改善研究所,退伍军人健康管理局,凯撒永久,和其他组织的专家。这些在卫生服务研究和质量改进方面的领导者致力于为患有严重的最终致命的慢性疾病的人提供安全可靠的护理,从那些患有晚期慢性心脏或肺衰竭的人开始。虽然它们有可能影响向所有美国人提供的医疗保健,但医疗差错和其他病人安全方面的失误不成比例地影响了年龄最大和病情最严重的病人,无论是在发病率还是在后果的严重性方面。 严重的长期疾病大多发生在生命的尽头,导致更多的错误,不良反应,以及在最需要安全,可靠,协调护理的人群中不稳定和不安全的治疗。重病患者经常会犯一系列错误,包括:不治疗疼痛、谵妄和其他症状;提供者计划内部和之间的常规中断;为了提供者的方便而选择护理地点,而不是效率或家庭支持;以及缺乏对提前护理计划的关注。该中心的目的是帮助提高医疗保健的可靠性显着,通过建设能力,通过有效的改变方法和知识的个人与慢性阻塞性肺疾病的慢性心力衰竭的安全和正确的护理改进。在第一阶段,该中心将建立一个强大的团队,发展与卫生服务系统的联系,制作教育材料,并为至少一项试点研究提出建议,该研究将在第二年和第三年进行。在第二阶段,中心将实施试点研究,提供教育材料,并为试点研究结果制定传播方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DORCAS JOANNE LYNN其他文献
DORCAS JOANNE LYNN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DORCAS JOANNE LYNN', 18)}}的其他基金
CLINICAL TRIAL: REBIF (IFN BETA-1A) AND BETASERON (IFN BETA-1B) IN IFN-NAIVE MS
临床试验:REBIF (IFN BETA-1A) 和 BETASERON (IFN BETA-1B) 在 IFN-NAIVE MS 中的应用
- 批准号:
7718678 - 财政年份:2007
- 资助金额:
$ 5万 - 项目类别:
Improving Influeza Immunization In Long Term Care Staff
改善长期护理人员的流感免疫接种
- 批准号:
7105670 - 财政年份:2004
- 资助金额:
$ 5万 - 项目类别:
Improving Influeza Immunization In Long Term Care Staff
改善长期护理人员的流感免疫接种
- 批准号:
6903350 - 财政年份:2004
- 资助金额:
$ 5万 - 项目类别:
A DETAILED PROFILE OF THE END-OF-LIFE CARE IN MEDICARE
医疗保险中临终关怀的详细概况
- 批准号:
6337256 - 财政年份:1999
- 资助金额:
$ 5万 - 项目类别:
A DETAILED PROFILE OF THE END-OF-LIFE CARE IN MEDICARE
医疗保险中临终关怀的详细概况
- 批准号:
6083371 - 财政年份:1999
- 资助金额:
$ 5万 - 项目类别:
PHASE 2 STUDY OF HU23F2G IN ACUTE EXACERBATIONS OF MULTIPLE SCLEROSIS
HU23F2G 在多发性硬化症急性发作中的 2 期研究
- 批准号:
6263476 - 财政年份:1998
- 资助金额:
$ 5万 - 项目类别:
相似海外基金
ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
- 批准号:
493118 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
- 批准号:
487508 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Operating Grants
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
- 批准号:
10633608 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
慢性阻塞性肺疾病精准治疗优化:动态治疗方案分析
- 批准号:
489950 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Operating Grants
Elucidation of the mechanism of sarcopenia associated with chronic obstructive pulmonary disease
阐明肌肉减少症与慢性阻塞性肺疾病相关的机制
- 批准号:
23K15702 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
- 批准号:
10700228 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
- 批准号:
10543560 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease
肺血管疾病是慢性阻塞性肺疾病呼吸系统疾病发病的一个原因
- 批准号:
10449417 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
- 批准号:
10772527 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别:
Fungal Translocation in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病中的真菌移位
- 批准号:
10610446 - 财政年份:2022
- 资助金额:
$ 5万 - 项目类别: